Xylocaine-Mpf 0.5% Inj, 50ml
Overview
What is this medicine?
How to Use This Medicine
For storage and disposal, consult with your doctor, nurse, or pharmacist to determine the best approach if you need to keep this medication at home.
If you miss a dose, contact your doctor promptly to receive guidance on the appropriate course of action.
Lifestyle & Tips
- Inform your healthcare provider about all medications you are taking, including over-the-counter drugs, supplements, and herbal products.
- Report any unusual symptoms or discomfort during or after the procedure.
- Avoid touching or putting pressure on the numb area until sensation returns to prevent injury.
Available Forms & Alternatives
Available Strengths:
- Xylocaine 4% Top Soln
- Xylocaine-Mpf 2% Inj, 10ml
- Xylocaine 2% Inj, 10ml
- Xylocaine-Mpf 1% Inj, 5ml
- Xylocaine 2% Inj, 20ml
- Xylocaine-Mpf 1% Inj, 30ml
- Xylocaine 2% Inj, 50ml
- Xylocaine-Mpf 0.5% Inj, 50ml
- Xylocaine-Mpf 1% Inj, 2ml
- Xylocaine-Mpf 2% Inj, 5ml
- Xylocaine 1% Inj, 20ml
- Xylocaine-Mpf 2% Inj, 2ml
- Xylocaine-Mpf 1% Inj, 10ml
- Xylocaine 1% Inj, 50ml
- Xylocaine 0.5% Inj, 50ml
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of methemoglobinemia (a rare but potentially life-threatening condition):
+ Blue or gray discoloration of the lips, nails, or skin
+ Abnormal heartbeat
+ Seizures
+ Severe dizziness or fainting
+ Severe headache
+ Excessive sleepiness
+ Feeling tired or weak
+ Shortness of breath
Signs of acidosis (too much acid in the blood):
+ Confusion
+ Rapid breathing
+ Rapid heartbeat
+ Abnormal heartbeat
+ Severe stomach pain, nausea, or vomiting
+ Excessive sleepiness
+ Shortness of breath
+ Feeling tired or weak
Other severe side effects:
+ Breathing difficulties, slow breathing, or shallow breathing
+ Feeling lightheaded, sleepy, confused, or experiencing blurred vision
+ Slow heartbeat
+ Feeling nervous or excitable
+ Speech difficulties
+ Abnormal burning, numbness, or tingling sensations
+ Restlessness
+ Anxiety
+ Changes in vision
+ Ringing in the ears
+ Dizziness or fainting
+ Severe headache
+ Twitching
+ Shakiness
+ Seizures
+ Feeling excessively hot or cold
+ Metallic taste
+ Chest pain
+ Mood changes
Additional Side Effects to Discuss with Your Doctor
If you are receiving this medication via spinal injection, you may also experience:
Erectile dysfunction
Loss of mobility
Loss of bladder or bowel control
Urination difficulties
Other Possible Side Effects
As with any medication, you may experience side effects that are not listed here. If you notice any symptoms that bother you or persist, contact your doctor for guidance. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Dizziness or lightheadedness
- Numbness or tingling around the mouth
- Metallic taste in the mouth
- Ringing in the ears (tinnitus)
- Blurred vision or double vision
- Slurred speech
- Tremors or muscle twitching
- Feeling unusually sleepy or confused
- Slow or irregular heartbeat
- Difficulty breathing
Before Using This Medicine
To ensure safe treatment, inform your doctor of the following:
Any allergies you have to this medication, its components, or other substances, including foods and drugs. Describe the allergic reactions you experienced.
If you are scheduled to receive this medication via spinal injection, tell your doctor if you have:
+ Heart block
+ Severe bleeding
+ Severe infection
+ An infection at the injection site
This list is not exhaustive. It is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health conditions with your doctor and pharmacist. They will help determine if it is safe to take this medication alongside your other treatments. Never start, stop, or adjust the dosage of any medication without first consulting your doctor.
Precautions & Cautions
It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication.
Risk of Methemoglobinemia
A severe blood condition called methemoglobinemia has been associated with drugs like this one. Your risk may be increased if you have:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Heart problems
- Lung problems
- Are taking certain other medications
- Are an infant younger than 6 months of age
If you have a history of methemoglobinemia, notify your doctor.
Sulfite Allergy
If you are allergic to sulfites, consult your doctor, as some products may contain sulfites.
Caution with Daily Activities
Avoid driving and performing tasks that require alertness until the effects of this medication have worn off and you feel fully awake.
Post-Treatment Precautions
If you are discharged before the numbness has resolved, protect the treated area from injury until you have regained sensation.
Special Considerations
- If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects.
- If the patient is a child, use this medication with caution, as the risk of certain side effects may be higher in children.
- If you are pregnant, plan to become pregnant, or are breastfeeding, discuss the benefits and risks with your doctor.
Injection into the Spine
This medication may cause temporary loss of sensation and motor function in the lower half of your body. Do not attempt to get out of bed or perform other activities until normal sensation and motor function have returned.
Mouth and Dental Procedures
Do not eat while your mouth is numb, as you may accidentally bite your tongue.
Overdose Information
Overdose Symptoms:
- Severe dizziness or lightheadedness
- Seizures
- Unconsciousness
- Respiratory arrest (stopping breathing)
- Severe low blood pressure
- Slow heart rate (bradycardia)
- Cardiac arrest
What to Do:
Immediate medical attention is required. Call 911 or emergency services. Management involves stopping the administration, ensuring airway patency, providing oxygen, managing seizures (e.g., with benzodiazepines), treating hypotension (e.g., with vasopressors), and managing arrhythmias. Intravenous lipid emulsion therapy may be considered for severe systemic toxicity.
Drug Interactions
Major Interactions
- Amiodarone (increased risk of cardiac depression/arrhythmias)
- Beta-blockers (e.g., Propranolol, Metoprolol - decreased lidocaine clearance, increased toxicity risk)
- Cimetidine (decreased lidocaine clearance, increased toxicity risk)
- Other Class I Antiarrhythmics (e.g., Procainamide, Quinidine, Disopyramide - additive cardiac effects, increased toxicity risk)
- Succinylcholine (prolonged neuromuscular blockade)
Moderate Interactions
- Phenytoin (increased lidocaine metabolism, potential for reduced effect; also additive cardiac effects)
- Rifampin (increased lidocaine metabolism, potential for reduced effect)
- Erythromycin (potential for increased lidocaine levels)
- Diltiazem, Verapamil (potential for increased lidocaine levels)
- Local anesthetics (additive systemic toxicity if multiple agents used)
Minor Interactions
- Not available
Monitoring
Baseline Monitoring
Rationale: To identify contraindications, risk factors for toxicity, and potential drug interactions.
Timing: Prior to administration
Rationale: To establish baseline and monitor for systemic effects.
Timing: Prior to administration
Routine Monitoring
Frequency: Continuously during and immediately after administration, then periodically for several hours.
Target: Absence of symptoms
Action Threshold: Any new or worsening CNS symptom warrants immediate intervention (stop infusion, provide supportive care).
Frequency: Continuously during and immediately after administration, then periodically for several hours.
Target: Stable vital signs, normal ECG rhythm
Action Threshold: Significant changes in vital signs or new arrhythmias warrant immediate intervention.
Frequency: As needed to assess efficacy.
Target: Adequate anesthesia for procedure
Action Threshold: Inadequate anesthesia may require re-dosing or alternative approach.
Symptom Monitoring
- Lightheadedness
- Dizziness
- Tinnitus
- Perioral numbness
- Metallic taste
- Slurred speech
- Nystagmus
- Tremors
- Muscle twitching
- Seizures
- Drowsiness
- Unconsciousness
- Respiratory depression/arrest
- Hypotension
- Bradycardia
- Cardiac arrhythmias
- Cardiac arrest
Special Patient Groups
Pregnancy
Generally considered safe for use as a local anesthetic during pregnancy when administered in appropriate doses. Category B. Studies in animals have not shown fetal harm, and human data suggest no increased risk of congenital anomalies.
Trimester-Specific Risks:
Lactation
Lidocaine is excreted into breast milk in small amounts. The amount ingested by the infant is typically very low and unlikely to cause adverse effects. Considered L2 (safer).
Pediatric Use
Use with caution. Children, especially infants, may be more susceptible to systemic toxicity due to differences in metabolism and distribution. Dosing must be carefully calculated based on weight (mg/kg) and maximum recommended doses should not be exceeded. Avoid concentrations higher than necessary. Monitor closely for signs of systemic toxicity.
Geriatric Use
Use with caution. Elderly patients may have reduced hepatic or renal function, decreased protein binding, and increased sensitivity to the systemic effects of lidocaine. Consider lower doses and monitor closely for toxicity. Reduced lean body mass and cardiac output may also affect pharmacokinetics.
Clinical Information
Clinical Pearls
- Always aspirate prior to injection to avoid intravascular administration, which can lead to rapid systemic toxicity.
- The addition of epinephrine prolongs the duration of action and reduces systemic absorption, allowing for higher total doses, but should not be used in areas with end-arterial circulation (e.g., fingers, toes, nose, penis, earlobe) due to risk of ischemia.
- Systemic toxicity typically manifests as CNS symptoms first (e.g., perioral numbness, tinnitus, lightheadedness), followed by more severe CNS effects (seizures) and then cardiovascular depression.
- The 'MPF' in Xylocaine-MPF stands for 'Methylparaben Free', which is important for certain uses like epidural or spinal anesthesia where preservatives can be neurotoxic.
- Ensure resuscitation equipment and medications (e.g., lipid emulsion, benzodiazepines) are readily available when administering large volumes or high concentrations of lidocaine.
Alternative Therapies
- Bupivacaine (longer duration, higher potency)
- Ropivacaine (similar to bupivacaine, less cardiotoxic)
- Mepivacaine (intermediate duration)
- Prilocaine (intermediate duration, risk of methemoglobinemia at high doses)
- Chloroprocaine (short duration, ester type)
- Topical anesthetics (e.g., EMLA cream, lidocaine patches for surface anesthesia)